Abstract

Background: The World Health Organization (WHO) HIV treatment guidelines have been used by various countries to revise their national guidelines. Our study discusses the national policy response to the HIV epidemic in sub-Saharan Africa and quantifies delays in adopting the WHO guidelines published in 2009, 2013 and 2015. Methods: From the Internet, health authorities and experts, and community members, we collected 59 published HIV guidelines from 33 countries in the sub-Saharan African region, and abstracted dates of publication and antiretroviral therapy (ART) eligibility criteria. For these 33 countries, representing 97% regional HIV burden in 2015, the number of months taken to adopt the WHO 2009, 2013 and/or 2015 guidelines were calculated to determine the average delay in months needed to publish revised national guidelines. Findings: Of the 33 countries, 3 (6% regional burden) are recommending ART according to the WHO 2015 guidelines (irrespective of CD4 count); 19 (65% regional burden) are recommending ART according to the WHO 2013 guidelines (CD4 count ≤ 500 cells/mm3); and 11 (26% regional burden) according to the WHO 2009 guidelines (CD4 count ≤ 350 cells/mm 3 ). The average time lag to WHO 2009 guidelines adoption in 33 countries was 24 (range 3–56) months. The 22 that have adopted the WHO 2013 guidelines took an average of 10 (range 0–36) months, whilst the three countries that adopted the WHO 2015 guidelines took an average of 8 (range 7–9) months. Conclusion: There is an urgent need to shorten the time lag in adopting and implementing the new WHO guidelines recommending ‘treatment for all’ to achieve the 90-90-90 targets.

Highlights

  • The rapid expansion of antiretroviral therapy (ART) has been a cornerstone in transforming the acquired immunodeficiency syndrome (AIDS) response globally

  • Our study looks at the national ART policy response to the HIV epidemic in subSaharan African countries, and quantifies delays in national level adoption of the World Health Organization (WHO) ART guidelines published in 2009, 2013 and 2015

  • Guidelines recommending ART according to the WHO 2009, 2013 or 2015 guidelines were not available and they were excluded from further analysis

Read more

Summary

Introduction

The rapid expansion of antiretroviral therapy (ART) has been a cornerstone in transforming the acquired immunodeficiency syndrome (AIDS) response globally. In March 2015, the ’15 by 15’ target set out in the 2011 United Nations Political Declaration on HIV and AIDS was achieved ahead of the deadline.[1] The greatest gains in access to ART occurred in sub-Saharan Africa, a region with 25.5 million people living with HIV.[2] treatment coverage remains relatively low. Our study discusses the national policy response to the HIV epidemic in sub-Saharan Africa and quantifies delays in adopting the WHO guidelines published in 2009, 2013 and 2015

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.